Hemispherx BioPharma (HEB)

[NickPar]

PR Oct 26 and Oct 23rd paperwork from Dr. Hasegawa

http://www.hemispherx.net/content/investor/default.asp?goto=654

Japanese NIH Expands Pandemic Flu Protective Potential by Ampligen®

......New Publication Suggests Pandemic Vaccines Adjuvanted are More Effective; The Potential Importance of Antigen Sparing and Cross-Protective Formulations



http://www.ncbi.nlm.nih.gov/pubmed/19840660?ordinalpos=1&itool=PPMCLayout.PPMCAppController.PPMCArticlePage.PPMCPubmedRA&linkpos=4


from Vaccine. 2009 Oct 23;27(45):6276-9
Title: PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.